ANXA5 and hepatocellular carcinoma: The same dose of FH535 that demonstrated anti-HCC activity (1 μM) did not induce any change in T cell viability in a 7-day culture as indicated by similar Annexin-V/PI staining pattern observed with or without FH535 (Fig. S2).